These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations]. Göretzlehner G; Wilken H Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480 [TBL] [Abstract][Full Text] [Related]
4. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results]. Signorelli I; Emanueli A Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438 [No Abstract] [Full Text] [Related]
5. [Clinical and biochemical effects of megestrol acetate allone and two megestrol acetate-estrogen combinations in gynecological indications]. Arnold M; Richter RH; Roth F Z Geburtshilfe Gynakol; 1969 Oct; 171(2):125-44. PubMed ID: 5355553 [No Abstract] [Full Text] [Related]
6. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418 [TBL] [Abstract][Full Text] [Related]
7. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation]. Krzywdziński K; Jedrzejewski M; Teter J Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038 [No Abstract] [Full Text] [Related]
9. [Hormonal treatment of juvenile menstruation disorders]. Sas M Fortschr Med; 1974 May; 92(15):641-2. PubMed ID: 4829461 [No Abstract] [Full Text] [Related]
10. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology]. Bernard I Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405 [No Abstract] [Full Text] [Related]
11. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)]. Kalchauer B Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578 [No Abstract] [Full Text] [Related]
12. [Indications for simultaneous estrogen and progestogen therapy]. Candotti G Attual Ostet Ginecol; 1967; 12(1):47-60. PubMed ID: 5628842 [No Abstract] [Full Text] [Related]
13. [Treatment of menopause disorders by the sequential method]. Gaudefroy M J Sci Med Lille; 1970 Dec; 88(12):637-49. PubMed ID: 4100661 [No Abstract] [Full Text] [Related]
14. [Use of a synthetic estro-progestational hormone: C. S. 1516 in gynecologic therapeutics. Apropos of 39 cases]. Guilhem P; Pontonnier A; Monrozies M; Pontonnier G; Bardenat M Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):327-33. PubMed ID: 4164208 [No Abstract] [Full Text] [Related]
15. [Sequential treatment in menstrual irregularities and ovulation disorders]. Bernard I Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):255-7. PubMed ID: 4164207 [No Abstract] [Full Text] [Related]
16. [Treatment of menstruation anomalies and preclimacteric disturbances by Duoluton]. Tscherne E Ther Ggw; 1970 Jan; 109(1):93-4 passim. PubMed ID: 5437260 [No Abstract] [Full Text] [Related]
17. Clinical observations on luteal phase inadequacy. Taubert HD; Jürgensen O; Becker H Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):586-94. PubMed ID: 4101703 [No Abstract] [Full Text] [Related]
19. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)]. Krause W; Böhm W; Müller W Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218 [No Abstract] [Full Text] [Related]